A Randomized Trial of Enhanced Therapy for Early Syphilis in Patients with and without Human Immunodeficiency Virus Infection

Since 1987, several reports have described neurosyphilis and other complications of syphilis in patients infected with the human immunodeficiency virus (HIV), 1 – 7 often after the patients have been treated with penicillin G benzathine, as recommended by the Centers for Disease Control and Preventi...

Full description

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 337; no. 5; pp. 307 - 314
Main Authors: Rolfs, Robert T, Joesoef, M. Riduan, Hendershot, Edward F, Rompalo, Anne M, Augenbraun, Michael H, Chiu, Michael, Bolan, Gail, Johnson, Steven C, French, Pamela, Steen, Eric, Radolf, Justin D, Larsen, Sandra, Brady, William E, Wagner, Kenneth F, D'Aquilante, Debra A
Format: Journal Article
Language:English
Published: Boston, MA Massachusetts Medical Society 31-07-1997
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since 1987, several reports have described neurosyphilis and other complications of syphilis in patients infected with the human immunodeficiency virus (HIV), 1 – 7 often after the patients have been treated with penicillin G benzathine, as recommended by the Centers for Disease Control and Prevention (CDC). Also, in 1987 viable treponemes were identified in the cerebrospinal fluid of two HIV-infected patients after this therapy. 8 These observations have prompted questions about the adequacy of the CDC-recommended treatment for HIV-infected patients with early syphilis. 3 , 9 – 11 The efficacy of the recommended therapy for patients with early syphilis who are not infected with HIV was . . .
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM199707313370504